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This study invesUgated the utility of systematically admin-
istering clonidine to detoxify opiate-dependent in-
patients. Fifteen patients received aO.1 mgdose of clon-
idine orally at 8:00 am, 12:00 noon, 4:00 pm, and at 
bedtime. A 0.1 mgdose was also administered as needed 
if any withdrawal signs were evidenced, but this addi-
tional dose was rarely needed after the second day of 
treatment. Night sweats were (he only significant com-
plaint reponed. AII15patientsweresuccessfullydetoxi-
fied after ten days of treatment. 
C lonidine hydrochloride is an alpha adrenergic agonist 
that may prove beneficial in the detoxification of opiate 
addicts. 
Recent studies (1-5) have shown that a single dose of 
clonidine, or several small doses throughout the day for 
ten days, relieve signs and symptoms of opiate withdraw-
al for both outpatients and inpatients. 
We studied the capability of clonidine to detoxify in-
patients addicted to opiates when the drug was admin-
istered systematically on a strict schedule. 
Patients 
The subjects were 15 opiate-dependent inpatients who 
requested detoxification. There were 11 men and four 
women ranging in age f rom 25 to 35 years. Their addic-
t ion ranged from two to 15 years, but they had no serious 
medical or psychiatric illnesses. Nine subjects were tak-
ing clinical maintenance doses of methadone (20-30 
mgs), three were actively abusing heroin, and three 
were abusing more than one drug simultaneously (meth-
adone, heroin, di laudid, tussionex, codeine, and other 
opiates in combination or singly with occasional use of 
various tranquilizers). Al l subjects had taken methadone 
and/or heroin on the day they were admitted to our 
hospital. On previous occasions, all had unsuccessfully 
attempted to withdraw from opiates, either by reducing 
their doses of methadone or by abstaining completely 
("cold turkey"). 
Methods 
Patients were started on oral doses of clonidine (0.1 mg) 
at 8:00 am, 12:00 noon, 4:00 pm, and at bedtime. A 0.1 
mg dose was also given as needed between each sched-
uled dose if the patient experienced any signs of w i th-
drawal. However, an additi9nal dose was rarely needed 
after the second day of treatment. The t ime between 
doses was riot to exceed four hours. Each patient's blood 
pressure was taken before and one hour after each dose. 
Clonidine was not administered when the systolic blood 
pressure was 90 mm or lower. This cut-off point was 
determined after we made numerous attemptsto imple-
ment a diastolic blood pressure and/or a higher systolic 
cut-off point but found that none would aid in the 
treatment. Wi th this regimen, no problems occurred 
either through a hypotensive episode or a disruption in 
the time span when clonidine was to be given. 
All 15 patients received this treatment for five days. On 
the sixth day, the4:00 pm dose of clonidine was omit ted 
first; on the seventh day, the 12:00 noon dose was omit-
ted; on the eighth day the 8:00 am dose; and, finally, on 
the ninth day, the dose at bedtime was omit ted. By the 
tenth day patients were not receiving clonidine atal l . If 
an extra dose had been added to this regimen (e.g., 
instead of receiving a 0.1 mg dosfe of clonidine at 4:00 
pm, the subject received 0.2 mg), this extra dose was 
omitted first. 
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Results 
All subjects were physically non-dependent on opiates 
after complet ing the ten-day treatment. Nine patients 
experienced night sweats on the second day of treat-
ment. No other significant complaints were reported. 
Neither the patient's body weight nor the length o f t ime 
the patient had been an addict affected our results. 
Comments 
Clonidine is best known to physicians as an anti-
hypertensive drug. However, several recent studies had 
reported its utility in the detoxification of opiate addicts 
(1-5). These studies provide clinical support for the 
hypothesis that non-adrenergic hyperactivity is involved 
in triggering the syndrome of opiate withdrawal. Our 
clinical test of systematically administered clonidine 
appears to be an effective regimen for opiate withdrawal 
in an inpatient setting. The need foran ongoing psycho-
social rehabilitation process for a minimum of six months 
after discharge is also a significant factor in helping sub-
jects to remain drug free. 
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